We are live on ! Find out more
RT

Robert Torray Torray Investment Partners

AUM $741M
1-Year Est. Return 26.16%
 

Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.

This Fund
S&P 500
This Quarter Est. Return
+6.24%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$715M
AUM Growth
+$45.2M
Cap. Flow
+$6.7M
Cap. Flow %
0.94%
Top 10 Hldgs %
30.36%
Holding
107
New
14
Increased
47
Reduced
34
Closed
5

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$6.31M
2
RPRX icon
Royalty Pharma
RPRX
+$4.55M
3
JNJ icon
Johnson & Johnson
JNJ
+$3.81M
4
CNA icon
CNA Financial
CNA
+$3.53M
5
HPE icon
Hewlett Packard
HPE
+$3.53M

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$11.1M
2
ANSS
Ansys
ANSS
+$5.89M
3
CSCO icon
Cisco
CSCO
+$3.33M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.81M
5
ORLY icon
O'Reilly Automotive
ORLY
+$2.04M

Sector Composition

Rank Sector Weight
1 Technology 26.08%
2 Financials 19.43%
3 Healthcare 14.29%
4 Industrials 11.47%
5 Consumer Discretionary 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
101
BioMarin Pharmaceuticals
BMRN
$12.9B
– –
-16,855
Closed -$1.39M
CSCO icon
102
Cisco
CSCO
$438B
– –
-70,134
Closed -$3.33M
MRK icon
103
Merck
MRK
$376B
– –
-1,705
Closed -$211K
TROW icon
104
T. Rowe Price
TROW
$23.8B
– –
-96,267
Closed -$11.1M
1 2 3 4
5

Similar funds

LGA
Lebenthal Global Advisors Hauppauge, New York $741M AUM 22.36% 1-Year Est. Return
SIC
SFE Investment Counsel Los Angeles, California $742M AUM 39.38% 1-Year Est. Return
CPC
Consolidated Planning Corp Atlanta, Georgia $742M AUM 25.54% 1-Year Est. Return
NC
Northcape Capital Sydney, Australia $742M AUM 2.34% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $742M AUM 17.39% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $742M AUM 23.98% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $741M AUM 78.82% 1-Year Est. Return
TPM
Triasima Portfolio Management Montreal, Quebec, Canada $740M AUM 69.74% 1-Year Est. Return

Robert Torray's Q3 2024 Portfolio in Review

As of Q3 2024, Robert Torray held 107 positions worth $715M, up 6.7% from $669M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Robert Torray's Q3 2024 filing shows 14 new, 47 increased, 34 reduced and 5 closed positions. Its largest new stake was Synopsys: 11,759 shares worth $5.95M. The largest sale was T. Rowe Price, an estimated $11.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Robert Torray's largest Q3 2024 buy was Synopsys: 11,759 shares worth $5.95M.
  • Robert Torray added most to Royalty Pharma in Q3 2024, an estimated $4.55M increase.
  • Robert Torray's biggest Q3 2024 reduction was Ansys, cutting an estimated $5.89M.
  • Robert Torray fully exited T. Rowe Price in Q3 2024, selling an estimated $11.1M.
  • Robert Torray's ten largest holdings make up 30% of its $715M portfolio in Q3 2024.
  • Robert Torray opened 14 new positions and closed 5 in Q3 2024.
  • Robert Torray's portfolio value rose 6.7% quarter-over-quarter to $715M.

Based on Torray Investment Partners's 13F filing for Q3 2024, filed 5 Nov 2024.